Weinheim, Germany

Klaus Strein

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 5.8

ph-index = 4

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Inventor Klaus Strein: A Pioneer in Bispecific Antibody Research

Introduction

Klaus Strein, an accomplished inventor based in Weinheim, Germany, holds an impressive portfolio of eight patents. His groundbreaking work in the field of biopharmaceuticals, particularly focusing on bispecific antibodies, has significant implications for the treatment of various diseases.

Latest Patents

Among his latest patents, Strein has developed bispecific antibodies targeting CD3EPSILON and ROR1. This particular invention involves innovative methods for the manufacture and therapeutic use of these bispecific antibodies, presenting new avenues for treatment. Another notable patent features bispecific antibodies that bind to the human carcinoembryonic antigen CEACAM5 and human CD47. This invention not only includes the antibodies but also covers the polynucleotides that encode them, vectors, and host cells containing these polynucleotides. Additionally, this patent outlines methodologies for selecting and producing such antibodies, with potential applications in monotherapy and combination therapies for various diseases.

Career Highlights

Klaus Strein has had a noteworthy career, contributing to the advancement of medical science through his innovative inventions. He has worked with leading companies such as Engmab Sàrl and Engmab AG, where he utilized his expertise to drive research and development in bispecific antibody technologies.

Collaborations

Throughout his career, Strein has collaborated with esteemed professionals in the industry, including Minh Diem Vu and Ekkehard Moessner. These partnerships have fostered a collaborative environment that has enriched his research endeavors, enabling the development of innovative solutions in the biomedical field.

Conclusion

Klaus Strein's work in the realm of bispecific antibodies underscores his significant contributions to medical research and innovation. With a total of eight patents, his inventions continue to pave the way for novel treatment options, embodying the spirit of invention and progress in the biopharmaceutical industry. His collaborative work with various professionals and companies further enhances the impact of his groundbreaking innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…